NHK World-Japan: Developing a new way to fight cancer
International news outlet focuses on the work of Atsuo Sasaki and his cancer research
Atsuo Sasaki, associate professor in the Department of Cancer Biology at the University of Cincinnati and a researcher within the UC Cancer Center, discovered the metabolic mechanism of cells which could open up new possibilities for cancer treatments. A molecule called GTP holds the key.
Sasaki uncovered that a certain enzyme which reacted to GTP in cells acts as an "energy sensor," sending signals for cancer cells to grow. Furthermore, his recent study revealed the mechanism causing nucleolus enlargement in certain cancer cells, a mystery for more than 100 years.
Currently, he is conducting joint research involving scientists at Cincinnati Children's Hospital Medical Center and the UC James L. Winkle College of Pharmacy to uncover how his findings could be connected to metabolic diseases related to obesity.
In addition to Sasaki, Timothy Pheonix, assistant professor at the UC James L. Winkle College of Pharmacy, is featured in this news story. NHK World-Japan is a state-owned international boadcaster aimed at overseas markets and is similar to BBC World News and CNN International.
Watch the full story and learn more about UC research.
Featured photo by Colleen Kelley/UC Creative Services
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
UC’s Ground Floor Makerspace births combat robots
April 17, 2024
In the heart of UC's 1819 Innovation Hub lies the Ground Floor Makerspace, an advanced and active hub of ingenuity where students, faculty and the community converge to bring their ideas to life. This includes being the birthplace of robots much like miniature race cars, combating fender to fender in an enclosed boxing ring. Combat robots like UC's Maximizer will again be fighting for first place in the National Havoc Robot League (NHRL) competition, slated for April 20.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.